Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant.

被引：0
|
作者：
Agrawal, A.
Hannon, R. A.
Cheung, K. L.
Eastell, R.
Robertson, J. F.
机构：
[1] City Hosp, Nottingham NG5 1PB, England
[2] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：47S / 47S
页数：1
相关论文
共 50 条
  • [21] Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole
    I. Kyvernitakis
    D. Knöll
    M. Struck
    O. Hars
    T. Bauer
    P. Hadji
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 159 - 166
  • [22] Fulvestrant in postmenopausal women with advanced breast cancer
    Bross, PF
    Baird, A
    Chen, G
    Jee, JM
    Lostritto, RT
    Morse, DE
    Rosario, LA
    Williams, GM
    Yang, PL
    Rahman, A
    Williams, G
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2003, 9 (12) : 4309 - 4317
  • [23] Role of fulvestrant in the management of postmenopausal breast cancer
    Krell, Jonathan
    Januszewski, Adam
    Yan, Kelvin
    Palmieri, Carlo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1641 - 1652
  • [24] The influence of bisphosphonates on bone turnover markers in patients (pts) with breast cancer (BC)
    Keller, A.
    Heim, K.
    Welzel, G.
    Findeisen, P.
    Neumaier, M.
    Wenz, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] BIOCHEMICAL MARKERS OF BONE TURNOVER IN PATIENTS WITH OSTEOLYSIS FROM BREAST-CANCER
    MONTI, M
    SCAZZOSO, A
    BEVILACQUA, M
    CALZAFERRI, G
    LOCATELLI, E
    CATANIA, S
    GANDINI, R
    CUNIETTI, E
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1990, 9 (03) : 145 - 150
  • [26] Fulvestrant does not stimulate endometrial growth in postmenopausal breast cancer patients
    Morales, L.
    Neven, P.
    Timmerman, D.
    Wildiers, H.
    Konstantinovic, M. L.
    Tan, P. N.
    Christiaens, M-R
    Paridaens, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S116 - S116
  • [27] The markers of bone turnover in patients with lung cancer
    Dane, Faysal
    Turk, H. Mehmet
    Sevinc, Alper
    Buyukberber, Suleyman
    Camci, Celalettin
    Tarakcioglu, Mehmet
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2008, 100 (04) : 425 - 428
  • [28] Comparison of biochemical markers of bone turnover in breast and prostate cancer patients with metastatic bone disease
    Lyubimova, Nina, V
    Pashkov, M. N.
    Kochergina, N., V
    TUMOR BIOLOGY, 2006, 27 : 110 - 110
  • [29] Correlation of CA15.3 levels with clinical response in advanced breast cancer (ABC) patients receiving fulvestrant.
    Robertson, J. F.
    Agrawal, A.
    Gutteridge, E.
    Cheung, K.
    Evans, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 38S - 38S
  • [30] BONE TURNOVER MARKERS RELATIONS TO POSTMENOPAUSAL OSTEOPOROSIS
    Jovcevska, Jasmina Mecevska
    Stratrova, Slavica Subeska
    Gjorgovski, Icko
    Gruev, Todor
    Kotevska, Mimoza Nikolovska
    Janicevic-Ivanovska, Daniela
    Petrovska, Emilija
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2009, 28 (03) : 161 - 165
12345